Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
IL0010852080
Biotechnology & Medical Research
| Market Cap | 222M 0 195M 183M 167M 312M 21.23B 315M 2.2B 852M 10.83B 832M 814M 35.1B | P/E 2026 * |
-8.36x | P/E 2027 * | -8.48x |
|---|---|---|---|---|---|
| Enterprise Value | 222M 0 195M 183M 167M 312M 21.23B 315M 2.2B 852M 10.83B 832M 814M 35.1B | EV / Sales 2026 * |
24x | EV / Sales 2027 * | 28.6x |
| Free-Float |
97.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compugen Ltd.
| 1 day | +10.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Eran Ophir
CEO | Chief Executive Officer | - | 23/09/2025 |
David Silberman
DFI | Director of Finance/CFO | 42 | 15/08/2024 |
Pierre Ferre
COO | Chief Operating Officer | 49 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Anat Cohen-Dayag
CHM | Chairman | 59 | 23/09/2025 |
Gilead Halevy
BRD | Director/Board Member | 59 | 11/06/2018 |
Sanford Zweifach
BRD | Director/Board Member | 70 | 11/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.90% | +2.00% | - | - | 222M | |
| +0.36% | +3.45% | +7.47% | +30.48% | 47.56B | |
| -0.83% | -0.36% | +43.66% | +34.77% | 44.09B | |
| -0.84% | +4.86% | +10.92% | +91.52% | 41.5B | |
| -1.10% | -2.64% | +331.49% | +535.80% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| -2.07% | +0.12% | +24.39% | +154.30% | 17.23B | |
| +0.39% | -0.52% | +23.55% | +39.72% | 15.06B | |
| -6.08% | -9.92% | - | - | 14.65B | |
| -0.78% | +9.46% | -8.96% | - | 13.82B | |
| Average | +0.03% | +0.69% | +54.21% | +133.23% | 29.39B | |
| Weighted average by Cap. | -0.76% | +0.96% | +67.93% | +141.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.24M 0 8.11M 7.62M 6.97M 13.02M 885M 13.12M 91.56M 35.49M 451M 34.7M 33.93M 1.46B | 7.75M 0 6.8M 6.39M 5.85M 10.92M 742M 11M 76.8M 29.77M 378M 29.1M 28.47M 1.23B |
| Net income | -26.46M -0 -23.23M -21.83M -19.96M -37.3M -2.54B -37.58M -262M -102M -1.29B -99.38M -97.21M -4.19B | -26.95M -0 -23.65M -22.24M -20.33M -37.99M -2.58B -38.27M -267M -104M -1.32B -101M -98.99M -4.27B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
